Connection

Allen Kaplan to Middle Aged

Back to Details
This is a "connection" page, showing publications Allen Kaplan has written about Middle Aged.
Allen Kaplan
Connection Strength
0.291
Middle Aged
  1. Omalizumab response in patients with chronic idiopathic urticaria: Insights from the XTEND-CIU study. J Am Acad Dermatol. 2018 04; 78(4):793-795.
    View in: PubMed
    Score: 0.041
  2. Timing and duration of omalizumab response in patients with chronic idiopathic/spontaneous urticaria. J Allergy Clin Immunol. 2016 Feb; 137(2):474-81.
    View in: PubMed
    Score: 0.036
  3. Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy. J Allergy Clin Immunol. 2013 Jul; 132(1):101-9.
    View in: PubMed
    Score: 0.031
  4. Omalizumab is effective in nonautoimmune urticaria. J Allergy Clin Immunol. 2011 May; 127(5):1300-2.
    View in: PubMed
    Score: 0.026
  5. Treatment of chronic autoimmune urticaria with omalizumab. J Allergy Clin Immunol. 2008 Sep; 122(3):569-73.
    View in: PubMed
    Score: 0.022
  6. TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction. J Allergy Clin Immunol. 2002 Apr; 109(4):694-700.
    View in: PubMed
    Score: 0.014
  7. Analysis of cold activation of the contact system in hereditary angioedema with normal C1 inhibitor. Mol Immunol. 2021 08; 136:150-160.
    View in: PubMed
    Score: 0.013
  8. The XTEND-CIU study: Long-term use of omalizumab in chronic idiopathic urticaria. J Allergy Clin Immunol. 2018 03; 141(3):1138-1139.e7.
    View in: PubMed
    Score: 0.010
  9. Omalizumab substantially improves dermatology-related quality of life in patients with chronic spontaneous urticaria. J Eur Acad Dermatol Venereol. 2017 Oct; 31(10):1715-1721.
    View in: PubMed
    Score: 0.010
  10. Angioedema in the omalizumab chronic idiopathic/spontaneous urticaria pivotal studies. Ann Allergy Asthma Immunol. 2016 10; 117(4):370-377.e1.
    View in: PubMed
    Score: 0.009
  11. Similar Efficacy with Omalizumab in Chronic Idiopathic/Spontaneous Urticaria Despite Different Background Therapy. J Allergy Clin Immunol Pract. 2015 Sep-Oct; 3(5):743-50.e1.
    View in: PubMed
    Score: 0.009
  12. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. N Engl J Med. 2013 Mar 07; 368(10):924-35.
    View in: PubMed
    Score: 0.008
  13. A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria. J Allergy Clin Immunol. 2011 Sep; 128(3):567-73.e1.
    View in: PubMed
    Score: 0.007
  14. Safety and tolerability of the direct renin inhibitor aliskiren in combination with angiotensin receptor blockers and thiazide diuretics: a pooled analysis of clinical experience of 12,942 patients. J Clin Hypertens (Greenwich). 2011 Jul; 13(7):506-16.
    View in: PubMed
    Score: 0.007
  15. Safety and tolerability of the direct renin inhibitor aliskiren: a pooled analysis of clinical experience in more than 12,000 patients with hypertension. J Clin Hypertens (Greenwich). 2010 Oct; 12(10):765-75.
    View in: PubMed
    Score: 0.006
  16. Development of a daily diary for patients with chronic idiopathic urticaria. Ann Allergy Asthma Immunol. 2010 Aug; 105(2):142-8.
    View in: PubMed
    Score: 0.006
  17. Studies of the cellular infiltrate of chronic idiopathic urticaria: prominence of T-lymphocytes, monocytes, and mast cells. J Allergy Clin Immunol. 1986 Nov; 78(5 Pt 1):914-8.
    View in: PubMed
    Score: 0.005
  18. Eucalyptus as a specific irritant causing vocal cord dysfunction. Ann Allergy Asthma Immunol. 2004 Sep; 93(3):299-303.
    View in: PubMed
    Score: 0.004
  19. Immunoreactive tissue kallikrein in human serum. J Lab Clin Med. 1984 May; 103(5):731-8.
    View in: PubMed
    Score: 0.004
  20. Histologic studies of chronic idiopathic urticaria. J Allergy Clin Immunol. 1983 Feb; 71(2):177-83.
    View in: PubMed
    Score: 0.004
  21. Identification of a new physically induced urticaria: cold-induced cholinergic urticaria. J Allergy Clin Immunol. 1981 Dec; 68(6):438-41.
    View in: PubMed
    Score: 0.003
  22. Idiopathic cold urticaria: in vitro demonstration of histamine release upon challenge of skin biopsies. N Engl J Med. 1981 Oct 29; 305(18):1074-7.
    View in: PubMed
    Score: 0.003
  23. Late asthmatic reactions provoked by intradermal injection of T-cell peptide epitopes are not associated with bronchial mucosal infiltration of eosinophils or T(H)2-type cells or with elevated concentrations of histamine or eicosanoids in bronchoalveolar fluid. J Allergy Clin Immunol. 2001 Sep; 108(3):394-401.
    View in: PubMed
    Score: 0.003
  24. The physical urticarias. Int J Dermatol. 1980 Oct; 19(8):417-35.
    View in: PubMed
    Score: 0.003
  25. A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol. 1999 Nov; 104(5):1071-8.
    View in: PubMed
    Score: 0.003
  26. Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways. J Clin Invest. 1975 Dec; 56(6):1650-62.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.